Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014.
作者信息
Kirkcaldy Robert D, Hook Edward W, Soge Olusegun O, del Rio Carlos, Kubin Grace, Zenilman Jonathan M, Papp John R
机构信息
Division of STD Prevention, US Centers for Disease Control and Prevention, Atlanta, Georgia.
University of Alabama, Birmingham.
出版信息
JAMA. 2015 Nov 3;314(17):1869-71. doi: 10.1001/jama.2015.10347.
Abstract
摘要
相似文献
1
Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014.2006 - 2014年美国淋病奈瑟菌对头孢菌素的敏感性趋势
JAMA. 2015 Nov 3;314(17):1869-71. doi: 10.1001/jama.2015.10347.
2
Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.淋病奈瑟菌分离株的头孢菌素药敏性——美国，2000-2010 年。
MMWR Morb Mortal Wkly Rep. 2011 Jul 8;60(26):873-7.
3
In vitro susceptibility of Spanish isolates of Neisseria gonorrhoeae to cefditoren and five other antimicrobial agents.西班牙淋病奈瑟菌分离株对头孢妥仑及其他五种抗菌药物的体外敏感性
Int J Antimicrob Agents. 2007 Apr;29(4):473-4. doi: 10.1016/j.ijantimicag.2006.10.014. Epub 2007 Feb 2.
4
Neisseria gonorrhoeae strain with reduced susceptibilities to extended-spectrum cephalosporins.对超广谱头孢菌素敏感性降低的淋病奈瑟菌菌株。
Emerg Infect Dis. 2014 Jul;20(7):1211-3. doi: 10.3201/eid2007.131396.
5
[Antimicrobal resistance of Neisseria gonorrhoeae strains in Hungary].[匈牙利淋病奈瑟菌菌株的抗菌耐药性]
Orv Hetil. 2015 Feb 8;156(6):226-9. doi: 10.1556/OH.2015.30079.
6
Gonococcal infections and emergence of gonococcal decreased susceptibility to cephalosporins in France, 2001 to 2012.2001年至2012年法国淋球菌感染及淋球菌对头孢菌素敏感性降低的情况
Euro Surveill. 2014 Aug 28;19(34):20885. doi: 10.2807/1560-7917.es2014.19.34.20885.
7
Update on the management of gonorrhea in adults in the United States.美国成人淋病管理的最新情况。
Clin Infect Dis. 2007 Apr 1;44 Suppl 3:S84-101. doi: 10.1086/511422.
8
Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada.加拿大淋病奈瑟菌对头孢菌素敏感性下降及对阿奇霉素耐药性增加
Emerg Infect Dis. 2016 Jan;22(1):65-7. doi: 10.3201/eid2201.151247.
9
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.淋病奈瑟菌抗菌药物敏感性监测 - 淋球菌分离株监测项目，美国 27 个监测点，2014 年。
MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.
10
Antimicrobial Drug Prescription and Neisseria gonorrhoeae Susceptibility, United States, 2005-2013.抗微生物药物处方与淋病奈瑟菌耐药性，美国，2005-2013 年。
Emerg Infect Dis. 2017 Oct;23(10):1657-1663. doi: 10.3201/eid2310.170488.
引用本文的文献
1
Dissemination of Neisseria gonorrhoeae with decreased susceptibility to extended-spectrum cephalosporins in Southern China, 2021: a genome-wide surveillance from 20 cities.2021 年中国南方地区对扩展谱头孢菌素敏感性降低的淋病奈瑟菌的传播：来自 20 个城市的全基因组监测。
Ann Clin Microbiol Antimicrob. 2023 May 17;22(1):39. doi: 10.1186/s12941-023-00587-x.
2
Resistance-Guided Therapy for Neisseria gonorrhoeae.淋病奈瑟菌耐药指导治疗。
Clin Infect Dis. 2022 Oct 29;75(9):1655-1660. doi: 10.1093/cid/ciac371.
3
Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.2009-2016 年，欧盟/欧洲经济区淋病奈瑟菌分离株的抗菌药物敏感性/耐药性与患者的性别、性取向和感染解剖部位的关系。
BMC Infect Dis. 2021 Mar 18;21(1):273. doi: 10.1186/s12879-021-05931-0.
4
Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.淋病耐药指导治疗：一项前瞻性临床研究。
Clin Infect Dis. 2021 Jul 15;73(2):298-303. doi: 10.1093/cid/ciaa596.
5
Emergence and Spread of Cephalosporin-Resistant Neisseria gonorrhoeae with Mosaic penA Alleles, South Korea, 2012-2017.2012-2017 年韩国出现具有 mosaic penA 等位基因的头孢菌素耐药淋病奈瑟菌的出现和传播。
Emerg Infect Dis. 2019 Mar;25(3):416-424. doi: 10.3201/eid2503.181503.
6
Trends and determinants of antimicrobial susceptibility of in the Netherlands, 2007 to 2015.2007 年至 2015 年荷兰耐抗生素 趋势和决定因素。
Euro Surveill. 2018 Sep;23(36). doi: 10.2807/1560-7917.ES.2018.23.36.1700565.
7
Molecular Characterization of Markers Associated With Antimicrobial Resistance in Neisseria gonorrhoeae Identified From Residual Clinical Samples.从残留临床样本中鉴定出的淋病奈瑟菌与抗菌药物耐药性相关标记物的分子特征。
Sex Transm Dis. 2018 May;45(5):312-315. doi: 10.1097/OLQ.0000000000000755.
8
Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand.新西兰淋病奈瑟菌的基因组流行病学和抗微生物药物耐药性。
J Antimicrob Chemother. 2018 Feb 1;73(2):353-364. doi: 10.1093/jac/dkx405.
9
Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study.评估淋病奈瑟菌中头孢克肟耐药性的适应性成本和益处以指导处方政策：一项建模研究。
PLoS Med. 2017 Oct 31;14(10):e1002416. doi: 10.1371/journal.pmed.1002416. eCollection 2017 Oct.
10
Antimicrobial Drug Prescription and Neisseria gonorrhoeae Susceptibility, United States, 2005-2013.抗微生物药物处方与淋病奈瑟菌耐药性，美国，2005-2013 年。
Emerg Infect Dis. 2017 Oct;23(10):1657-1663. doi: 10.3201/eid2310.170488.
本文引用的文献
1
Gonococcal susceptibility to cephalosporins--Hawaii, 2003 to 2011.淋球菌对头孢菌素类药物的敏感性-夏威夷，2003 年至 2011 年。
Sex Transm Dis. 2013 Sep;40(9):756-9. doi: 10.1097/01.olq.0000431357.18959.30.
2
Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.淋病奈瑟菌对头孢菌素类药物的敏感性降低：来自 2007-2011 年英格兰和威尔士淋球菌对抗微生物药物耐药性监测计划（GRASP）的数据。
Lancet Infect Dis. 2013 Sep;13(9):762-8. doi: 10.1016/S1473-3099(13)70143-9. Epub 2013 Jun 11.
3
Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.美国疾病预防控制中心性传播疾病治疗指南更新，2010 年：口服头孢菌素不再作为淋球菌感染的推荐治疗方法。
MMWR Morb Mortal Wkly Rep. 2012 Aug 10;61(31):590-4.
Zotero 插件